Hence, these AGE-RAGE signaling pathways play a vital role in the emergence and clinical progression of AD and also hint at the possibility that targeting these pathways would be a cornerstone to slow cognitive decline and progression in AD patients (Twarda-Clapa et al., 2022). Here, RENBP is linked to Alzheimer disease.